-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HeZEh+V2COWYUiapNAsvh6nNs/jLiKTah4VbCEcoalD0GV/bgvp0aj2RrsEFnGJZ 5ggEG7x3vDp7YthQ2vrs3A== /in/edgar/work/0000950131-00-006209/0000950131-00-006209.txt : 20001110 0000950131-00-006209.hdr.sgml : 20001110 ACCESSION NUMBER: 0000950131-00-006209 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20001102 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 20001109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOREX CORP CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: [2834 ] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-16929 FILM NUMBER: 757547 BUSINESS ADDRESS: STREET 1: 28101 BALLARD DR. CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 847-573-8990 MAIL ADDRESS: STREET 1: 28101 BALLARD DR. CITY: LAKE FOREST STATE: IL ZIP: 60045 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 8-K 1 0001.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2000 ---------------- Endorex Corporation ----------------------------------------------------------------- (Exact Name of Registrant as Specified in its Charter) Delaware ----------------------------------------------------------------- (State or Other Jurisdiction of Incorporation) 1-14778 41-1505029 - --------------------------------- ------------------------------------------ (Commission File Number) (I.R.S. Employer Identification No.) 28101 Ballard Drive, Suite F, Lake Forest, IL 60045 ------------------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) (847) 573-8990 ----------------------------------------------------------------- (Registrant's Telephone Number, Including Area Code) Item 4. Change in Registrant's Certifying Accountants ------ (a) (i) On November 2, 2000, the Registrant engaged Ernst & Young LLP as its Independent public accountant and dismissed PricewaterhouseCoopers LLP ("PwC"). (ii) PwC's reports on the financial statements of the Registrant for the past two fiscal years did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principle. (iii) The decision to change independent public accountants was recommended and approved by the Registrant's Audit Committee. (iv) In connection with its audits for the two most recent fiscal years and through November 2, 2000, there have been no disagreements with PwC on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to PwC's satisfaction, would have caused them to make reference to the subject matter of the disagreements in their report on the financial statements for such years. (v) During the two most recent fiscal years and through November 2, 2000 there were no reportable events except that in connection with its review of the June 30, 2000 financial statements, PwC reported a material weakness in the Registrant's internal control structure relative to the employees of the Registrant not having expertise in the area of generally accepted accounting principles and financial reporting procedures. The Registrant did not have a certified public accountant on its full-time staff at that time. The Registrant has since hired a certified public accountant to serve as the Registrant's corporate controller. The Registrant's management and Audit Committee believe that the concerns expressed by PwC have been adequately addressed with the hiring of the certified public accountant as controller. (vi) In accordance with the requirements of Item 304(a)(3) of Regulation S-B, the Registrant has requested that PwC furnish it with a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the above statements. A copy of such letter dated November 9, 2000, is filed as exhibit 16.1 to this Form 8-K. (b) Ernst & Young L.L.P. ("E&Y") was engaged by the Registrant on November 2, 2000 as the Registrant's independent public accountant. E&Y was not consulted by the Registrant with respect to the application of accounting principles to a specific completed transaction or contemplated transaction, or the type of audit opinion that might be rendered on the Registrant's financial statements. The Registrant provided a copy of PwC's letter reporting the material weakness to E&Y and authorized PwC to respond fully to the inquiries of E&Y regarding the letter. Item 7. Financial Statements, Pro Forma Financial Information and ------ Exhibits Exhibit 16.1 - Letter from PricewaterhouseCoopers LLP to the Securities and Exchange Commission dated November 9, 2000. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Endorex Corporation ------------------- (Registrant) By: _________________________________ Name: Frank C. Reid Title: Vice President, Finance and Corporate Development Dated: November 9, 2000 EX-16.1 2 0002.txt LETTER FROM PRICEWATERHOUSECOOPERS, LLP Exhibit 16.1 [PriceWaterhouseCoopers LLP Letterhead] November 9, 2000 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, DC 20549 Commissioners: We have read the statements made by Endorex Corporation (copy attached), which we understand will be filed with the Commission, pursuant to Item 4 of Form 8-K, as part of the Company's Form 8-K report dated November 2, 2000. We agree with the statements concerning our Firm in such Form 8-K. As to the last sentence of paragraph (v), we have no basis to agree or disagree with such statement. Very truly yours, /s/ PricewaterhouseCoopers LLP -----END PRIVACY-ENHANCED MESSAGE-----